(A) Interleaved box and whiskers plot of fold change in GSH and GSSG with FHIN-1 (20 μM)-, AA5 (1 μM)- and TTFA (500 μM)-treated Fh1fl/fl cells versus DMSO-treated Fh1fl/fl cells (24 hr timepoint) (n = 5 independent biological replicates). p values determined by unpaired two-tailed t-test. p < 0.05*; p < 0.01**; p < 0.001***. (B) U-13C-glutamine tracing into α-KG, succinate, fumarate, malate, citrate, cis-aconitate, and 2-HG (total isotopologue fraction distribution) in DMSO and mitoCDNB (10 μM)-treated Fh1fl/fl cells (24 hr timepoint) (n = 5 independent biological replicates). (C) U-13C-glutamine tracing into α-KG, succinate, fumarate, malate, citrate, cis-aconitate, and 2-HG (m + 5 and m + 3 labeling intensity) in DMSO and mitoCDNB (10 μM)-treated Fh1fl/fl cells (24 hr timepoint) (n = 5 independent biological replicates). (D) ATP/ADP, lactate/pyruvate and NADH/NAD+ ratio in DMSO and mitoCDNB (10 μM)-treated Fh1fl/fl cells (24 hr timepoint) (n = 5 independent biological replicates). Data are mean ± SEM. p Values determined by unpaired two-tailed t-test. p < 0.05*; p < 0.01**; p < 0.001***.